CHAIN 1 781 Catenin beta-1.
/FTId=PRO_0000064271.
REPEAT 151 191 ARM 1.
REPEAT 193 234 ARM 2.
REPEAT 235 276 ARM 3.
REPEAT 277 318 ARM 4.
REPEAT 319 360 ARM 5.
REPEAT 361 389 ARM 6.
REPEAT 400 441 ARM 7.
REPEAT 442 484 ARM 8.
REPEAT 489 530 ARM 9.
REPEAT 531 571 ARM 10.
REPEAT 594 636 ARM 11.
REPEAT 637 666 ARM 12.
REGION 1 23 Interaction with VCL (By similarity).
REGION 772 781 Interaction with SCRIB (By similarity).
MOD_RES 23 23 Phosphoserine; by GSK3-beta.
MOD_RES 29 29 Phosphoserine; by GSK3-beta.
MOD_RES 33 33 Phosphoserine; by GSK3-beta and HIPK2.
MOD_RES 37 37 Phosphoserine; by GSK3-beta and HIPK2.
MOD_RES 41 41 Phosphothreonine; by GSK3-beta.
MOD_RES 45 45 Phosphoserine.
MOD_RES 64 64 Phosphotyrosine; by PTK6.
MOD_RES 86 86 Phosphotyrosine; by CSK.
MOD_RES 142 142 Phosphotyrosine; by FYN and PTK6.
MOD_RES 191 191 Phosphoserine; by CDK5.
MOD_RES 246 246 Phosphoserine; by CDK5.
MOD_RES 331 331 Phosphotyrosine; by PTK6.
MOD_RES 333 333 Phosphotyrosine; by PTK6 (Probable).
MOD_RES 551 551 Phosphothreonine.
MOD_RES 552 552 Phosphoserine; by AMPK (Probable).
MOD_RES 556 556 Phosphothreonine.
MOD_RES 654 654 Phosphotyrosine; by CSK.
MOD_RES 675 675 Phosphoserine.
VAR_SEQ 1 565 Missing (in isoform 2).
/FTId=VSP_006984.
VAR_SEQ 652 653 AT -> GK (in isoform 2).
/FTId=VSP_006985.
VAR_SEQ 654 781 Missing (in isoform 2).
/FTId=VSP_006986.
VARIANT 23 23 S -> R (in hepatocellular carcinoma; no
effect).
/FTId=VAR_017612.
VARIANT 25 33 Missing (in hepatocellular carcinoma).
/FTId=VAR_017613.
VARIANT 32 32 D -> A (in hepatocellular carcinoma).
/FTId=VAR_017614.
VARIANT 32 32 D -> G (in PTR and hepatocellular
carcinoma).
/FTId=VAR_017615.
VARIANT 32 32 D -> Y (in PTR, hepatoblastoma and
hepatocellular carcinoma;
dbSNP:rs28931588).
/FTId=VAR_017616.
VARIANT 33 33 S -> F (in PTR, MDB and hepatocellular
carcinoma).
/FTId=VAR_017617.
VARIANT 33 33 S -> L (in hepatocellular carcinoma).
/FTId=VAR_017618.
VARIANT 33 33 S -> Y (in colorectal cancer and PTR;
enhances transactivation of target
genes).
/FTId=VAR_017619.
VARIANT 34 34 G -> E (in PTR).
/FTId=VAR_017620.
VARIANT 34 34 G -> R (in hepatocellular carcinoma).
/FTId=VAR_017621.
VARIANT 34 34 G -> V (in hepatoblastoma;
dbSNP:rs28931589).
/FTId=VAR_017622.
VARIANT 35 35 I -> S (in hepatocellular carcinoma).
/FTId=VAR_017623.
VARIANT 37 38 SG -> W (in hepatocellular carcinoma).
/FTId=VAR_017628.
VARIANT 37 37 S -> A (in MDB and hepatocellular
carcinoma; enhances transactivation of
target genes).
/FTId=VAR_017624.
VARIANT 37 37 S -> C (in PTR, hepatoblastoma and
ovarian cancer).
/FTId=VAR_017625.
VARIANT 37 37 S -> F (in PTR).
/FTId=VAR_017626.
VARIANT 37 37 S -> Y (in hepatocellular carcinoma).
/FTId=VAR_017627.
VARIANT 41 41 T -> A (in hepatoblastoma and
hepatocellular carcinoma; also in a
desmoid tumor; strongly reduces
phosphorylation and degradation;
abolishes phosphorylation on Ser-33 and
Ser-37 and enhances transactivation of
target genes).
/FTId=VAR_017629.
VARIANT 41 41 T -> I (in PTR, hepatocellular carcinoma
and ovarian cancer).
/FTId=VAR_017630.
VARIANT 45 45 S -> F (in hepatocellular carcinoma).
/FTId=VAR_017631.
VARIANT 45 45 S -> P (in hepatocellular carcinoma).
/FTId=VAR_017632.
VARIANT 45 45 Missing (in colorectal cancer).
/FTId=VAR_055430.
VARIANT 688 688 M -> V (in dbSNP:rs4135384).
/FTId=VAR_018954.
MUTAGEN 29 29 S->F: No effect.
MUTAGEN 64 64 Y->F: Abolishes phosphorylation by PTK6.
MUTAGEN 253 253 F->A: Abolishes or strongly reduces AXIN2
binding.
MUTAGEN 260 260 H->A: Abolishes or strongly reduces AXIN1
and AXIN2 binding. Strongly reduces
phosphorylation and degradation; when
associated with A-386 and A-383.
MUTAGEN 292 292 K->A: Abolishes or strongly reduces AXIN1
and AXIN2 binding.
MUTAGEN 312 312 K->E: Abolishes TCF7L2 binding.
MUTAGEN 345 345 K->A: Abolishes APC binding.
MUTAGEN 383 383 W->A: Abolishes APC binding. Strongly
reduces phosphorylation and degradation;
when associated with A-260 and A-386.
MUTAGEN 386 386 R->A: Strongly reduces APC binding.
Strongly reduces phosphorylation and
degradation; when associated with A-260
and A-383.
MUTAGEN 426 426 N->A: Abolishes TCF7L2 and LEF1 binding.
MUTAGEN 435 435 K->A: Strongly reduces or abolishes LEF1
binding.
MUTAGEN 435 435 K->E: Abolishes TCF7L2 binding.
MUTAGEN 469 469 R->A: Abolishes TCF7L2 binding, and
strongly reduces or abolishes LEF1
binding.
MUTAGEN 470 470 H->A: Abolishes TCF7L2 binding, and
strongly reduces or abolishes LEF1
binding.
MUTAGEN 508 508 K->A: Abolishes TCF7L2 and LEF1 binding.
MUTAGEN 654 654 Y->E: Enhances TBP binding and
transactivation of target genes.
MUTAGEN 654 654 Y->F: Abolishes increase of TBP binding
after phosphorylation by CSK.
MUTAGEN 660 660 F->A: Abolishes CTNNBIP1 binding; when
associated with A-661.
MUTAGEN 661 661 R->A: Abolishes CTNNBIP1 binding; when
associated with A-660.
TURN 20 22
STRAND 23 26
TURN 27 29
TURN 39 41
HELIX 135 150
HELIX 152 160
HELIX 165 179
HELIX 182 189
HELIX 192 204
HELIX 208 221
HELIX 225 233
HELIX 236 243
HELIX 249 265
HELIX 269 276
HELIX 278 284
HELIX 285 287
HELIX 291 305
HELIX 309 317
HELIX 320 330
HELIX 334 347
HELIX 353 359
HELIX 362 367
TURN 368 371
HELIX 375 389
HELIX 399 408
HELIX 414 427
TURN 428 430
HELIX 432 440
HELIX 443 454
HELIX 458 471
STRAND 473 475
HELIX 478 487
HELIX 491 496
HELIX 504 517
HELIX 521 523
HELIX 524 529
HELIX 532 547
STRAND 550 552
STRAND 554 557
STRAND 561 563
HELIX 566 580
HELIX 584 592
HELIX 596 601
HELIX 602 604
HELIX 608 621
HELIX 625 633
HELIX 637 642
HELIX 643 645
HELIX 649 662
TURN 663 665
HELIX 668 682
HELIX 688 690
STRAND 778 780
Back to Top